Immunic Debt Ratio from 2010 to 2025

IMUX Stock  USD 1.15  0.01  0.88%   
Immunic Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.03 in 2025. During the period from 2010 to 2025, Immunic Debt Ratio regression line of annual values had r-squared of  0.28 and arithmetic mean of  1.13. View All Fundamentals
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.0283
Current Value
0.0268
Quarterly Volatility
1.23812549
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 94.9 K, Interest Expense of 730.2 K or Other Operating Expenses of 119.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Latest Immunic's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Immunic over the last few years. It is Immunic's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
Debt Ratio10 Years Trend
Slightly volatile
   Debt Ratio   
       Timeline  

Immunic Debt Ratio Regression Statistics

Arithmetic Mean1.13
Geometric Mean0.18
Coefficient Of Variation109.88
Mean Deviation1.19
Median0.27
Standard Deviation1.24
Sample Variance1.53
Range2.4791
R-Value(0.53)
Mean Square Error1.19
R-Squared0.28
Significance0.04
Slope(0.14)
Total Sum of Squares22.99

Immunic Debt Ratio History

2025 0.0268
2024 0.0283
2023 0.0246
2022 0.0122
2021 0.004198
2020 0.004045
2019 0.007884

Other Fundumenentals of Immunic

Immunic Debt Ratio component correlations

0.97-0.95-0.020.55-0.540.97-0.23-0.470.260.330.13-0.390.720.410.780.74-0.410.25
0.97-0.93-0.070.53-0.730.94-0.14-0.610.310.150.11-0.390.620.40.680.63-0.410.19
-0.95-0.930.0-0.640.55-0.980.350.47-0.32-0.33-0.180.21-0.6-0.24-0.69-0.710.21-0.12
-0.02-0.070.00.060.23-0.09-0.160.32-0.860.05-0.810.56-0.2-0.510.220.16-0.29-0.66
0.550.53-0.640.06-0.310.63-0.32-0.430.290.340.220.00.180.050.070.110.110.26
-0.54-0.730.550.23-0.31-0.54-0.170.81-0.380.37-0.050.29-0.11-0.26-0.13-0.070.26-0.01
0.970.94-0.98-0.090.63-0.54-0.35-0.440.370.390.27-0.310.710.330.70.72-0.20.29
-0.23-0.140.35-0.16-0.32-0.17-0.35-0.170.06-0.65-0.16-0.53-0.190.56-0.25-0.42-0.46-0.01
-0.47-0.610.470.32-0.430.81-0.44-0.17-0.470.26-0.160.360.06-0.350.020.140.25-0.15
0.260.31-0.32-0.860.29-0.380.370.06-0.47-0.010.88-0.490.230.49-0.11-0.030.360.59
0.330.15-0.330.050.340.370.39-0.650.26-0.010.370.010.490.070.390.510.270.37
0.130.11-0.18-0.810.22-0.050.27-0.16-0.160.880.37-0.40.330.44-0.090.060.580.71
-0.39-0.390.210.560.00.29-0.31-0.530.36-0.490.01-0.4-0.46-0.94-0.24-0.130.45-0.58
0.720.62-0.6-0.20.18-0.110.71-0.190.060.230.490.33-0.460.510.760.8-0.190.56
0.410.4-0.24-0.510.05-0.260.330.56-0.350.490.070.44-0.940.510.290.17-0.390.59
0.780.68-0.690.220.07-0.130.7-0.250.02-0.110.39-0.09-0.240.760.290.96-0.480.0
0.740.63-0.710.160.11-0.070.72-0.420.14-0.030.510.06-0.130.80.170.96-0.240.03
-0.41-0.410.21-0.290.110.26-0.2-0.460.250.360.270.580.45-0.19-0.39-0.48-0.240.17
0.250.19-0.12-0.660.26-0.010.29-0.01-0.150.590.370.71-0.580.560.590.00.030.17
Click cells to compare fundamentals

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Debt Ratio 0.03  0.03 
Cash Flow To Debt Ratio(61.06)(64.11)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.